Saad Khan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Saad Khan has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
Abha Kaul
Department of Gastroenterology Peninsula Health Melbourne Victoria Australia
1 shared publicationAlan Moss
Department of Gastroenterology Western Health Melbourne Victoria Australia
1 shared publicationAllan Avery
I‐Med Radiology, Wesley Hospital Brisbane Queensland Australia
1 shared publicationAndrew J Metz
Department of Gastroenterology Royal Melbourne Hospital Melbourne Victoria Australia
1 shared publicationAndrew St John
Department of Gastroenterology and Hepatology Princess Alexandra Hospital Brisbane Queensland Australia
1 shared publicationAndrew Trinh
Department of Gastroenterology Royal Melbourne Hospital Melbourne Victoria Australia
1 shared publication
Latest Publications
- 9 June 2026
- Published by Elsevier in BJA Education
- Vol. 26 (7) , 277-284
Anaesthesia for antireflux and achalasia surgery
- 9 June 2026
- Published by Elsevier in BJA Education
- Vol. 26 (7) , 277-284
Anaesthesia for antireflux and achalasia surgery
- 23 December 2025
- Published by Wiley in Anz Journal of Surgery
Successful Management of an Abdominal Fistularising Lymphoma Without Surgery
- 23 December 2025
- Published by Wiley in Anz Journal of Surgery
Successful Management of an Abdominal Fistularising Lymphoma Without Surgery
- 9 August 2021
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 36 (12) , 3395-3401
Drainage of pancreatic fluid collections using a lumen‐apposing metal stent with an electrocautery‐enhanced delivery system
Background and Aim: Our aim was to evaluate the efficacy and safety of a lumen‐apposing metal stent with an electrocautery‐enhanced delivery system (EDS‐LAMS) for endoscopic ultrasound (EUS)‐guided drainage of pancreatic fluid collections (PFCs) in regular clinical practice.Methods: A retrospective and subsequent prospective analysis was undertaken of all patients who underwent EUS‐guided drainage of their PFCs using the EDS‐LAMS at 17 tertiary therapeutic endoscopy centers.Results: Two hundred eight cases of EDS‐LAMS deployment were attempted in 202 patients (mean age 52.9 years) at time of evaluation. Ninety‐seven patients had pancreatic pseudocysts (PPs), 75 walled‐off pancreatic necrosis (WOPN), 10 acute peripancreatic fluid collections (APFCs), 6 acute necrotic collections (ANCs), and 14 postoperative collections (POCs). Procedural technical success was achieved in 202/208 cases (97.1%). Maldeployment occurred in 7/208 cases (3.4%). Clinical success was achieved in 142/160 (88.8%) patients (PP 90%, WOPN 85.2%, APFC 100%, ANC 75%, POC 100%). Delayed adverse events included stent migration in 15/202 (7.4%), stent occlusion and infection in 16/202 (7.9%), major bleeding in 4/202 (2%), and buried EDS‐LAMS in 2/202 (1%). PFC recurrence occurred in 13/142 (9.2%) patients; 9/202 (4.5%) required surgical or radiological intervention for PFC management after EDS‐LAMS insertion.Conclusions: This large international multicenter study evaluating the EDS‐LAMS for drainage of PFCs in routine clinical practice suggests that the EDS‐LAMS are safe and effective for drainage of all types of PFCs; however, further endoscopic therapy is often required for WOPN. Major bleeding was a rare complication in our cohort.
- 9 August 2021
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 36 (12) , 3395-3401
Drainage of pancreatic fluid collections using a lumen‐apposing metal stent with an electrocautery‐enhanced delivery system
Background and Aim: Our aim was to evaluate the efficacy and safety of a lumen‐apposing metal stent with an electrocautery‐enhanced delivery system (EDS‐LAMS) for endoscopic ultrasound (EUS)‐guided drainage of pancreatic fluid collections (PFCs) in regular clinical practice.Methods: A retrospective and subsequent prospective analysis was undertaken of all patients who underwent EUS‐guided drainage of their PFCs using the EDS‐LAMS at 17 tertiary therapeutic endoscopy centers.Results: Two hundred eight cases of EDS‐LAMS deployment were attempted in 202 patients (mean age 52.9 years) at time of evaluation. Ninety‐seven patients had pancreatic pseudocysts (PPs), 75 walled‐off pancreatic necrosis (WOPN), 10 acute peripancreatic fluid collections (APFCs), 6 acute necrotic collections (ANCs), and 14 postoperative collections (POCs). Procedural technical success was achieved in 202/208 cases (97.1%). Maldeployment occurred in 7/208 cases (3.4%). Clinical success was achieved in 142/160 (88.8%) patients (PP 90%, WOPN 85.2%, APFC 100%, ANC 75%, POC 100%). Delayed adverse events included stent migration in 15/202 (7.4%), stent occlusion and infection in 16/202 (7.9%), major bleeding in 4/202 (2%), and buried EDS‐LAMS in 2/202 (1%). PFC recurrence occurred in 13/142 (9.2%) patients; 9/202 (4.5%) required surgical or radiological intervention for PFC management after EDS‐LAMS insertion.Conclusions: This large international multicenter study evaluating the EDS‐LAMS for drainage of PFCs in routine clinical practice suggests that the EDS‐LAMS are safe and effective for drainage of all types of PFCs; however, further endoscopic therapy is often required for WOPN. Major bleeding was a rare complication in our cohort.